HFPP White Papers

When evaluating the effectiveness of efforts to combat healthcare fraud, waste, and abuse, return on investment (ROI) is a key metric. Using case studies featuring Medicare claims data and HFPP Partner insights, this HFPP white paper provides a recommended approach to measuring the value of anti-fraud initiatives, demonstrates the importance of including deterrence in ROI calculations, and outlines strategies for doing so.

• Download the Measuring the Value of Healthcare Anti-Fraud Efforts White Paper (PDF)
• View and Share the Measuring the Value of Healthcare Anti-Fraud Efforts Information Sheet (PDF)

Developed with direct insight from HFPP Partners, this white paper provides background on the use of telehealth services prior to and during the COVID-19 Public Health Emergency, identifies fraud schemes that take advantage of increased telehealth usage, and offers numerous strategies to help anticipate and reduce related vulnerabilities.

• Download the Exploring Fraud, Waste, and Abuse Within Telehealth White Paper (PDF)
• View and Share the Exploring Fraud, Waste, and Abuse Within Telehealth Information Sheet (PDF)

As a result of COVID-19, there were comprehensive changes to the nation’s healthcare system, creating potential vulnerabilities for healthcare fraud, waste, and abuse. In response, the HFPP developed this white paper which provides background on the impact of COVID-19, outlines associated schemes, and offers the latest methods to detect, mitigate, and prevent fraud, waste, and abuse related to the delivery of care for COVID-19.

• Download the Fraud, Waste, and Abuse in the Context of COVID-19 White Paper (PDF)
• View and Share the Fraud, Waste, and Abuse in the Context of COVID-19 Information Sheet (PDF)

The HFPP developed this paper in collaboration with Stanford University School of Medicine in response to the growing issue of fraud, waste, and abuse in genetic testing. The White Paper provides an overview of clinical genetic testing services, examines fraud, waste, and abuse schemes in the field of genetic testing, and presents possible actions that payers can take to address this issue.

• Download the Genetic Testing Fraud, Waste, and Abuse White Paper (PDF)
• View and Share the Genetic Testing Fraud, Waste, and Abuse White Paper Fact Sheet (PDF)

The HFPP examined clinical laboratory services, which can be a significant target for potential fraud and abuse. This White Paper explores systematic challenges that make laboratory services vulnerable to fraud and abuse, as well as describing specific types of fraud and abuse schemes identified by HFPP Partner organizations.

• Download the Clinical Laboratory Services White Paper (PDF)
• View and Share the Clinical Laboratory Services Infographic (PDF)

The HFPP has taken action to curb the nation’s opioid crisis. Learn what we are doing to reduce the harms of opioids while ensuring access to medically necessary therapies and reducing fraud, waste, and abuse.

• Download the Reducing the Harms of Opioids White Paper (PDF)
• View and Share Strategies to Reduce the Harms of Opioids Infographic (PDF)